escitalopram / Generic mfg. |
NCT00667121: Tamoxifen in Women With Breast Cancer and in Women at High-Risk of Breast Cancer Who Are Receiving Venlafaxine, Citalopram, Escitalopram, Gabapentin, or Sertraline |
|
|
| Active, not recruiting | N/A | 85 | US | citalopram hydrobromide, escitalopram oxalate, gabapentin, sertraline hydrochloride, tamoxifen citrate, venlafaxine, molecular genetic technique, high performance liquid chromatography, laboratory biomarker analysis, pharmacological study, adjuvant therapy | Mayo Clinic, National Cancer Institute (NCI) | Breast Cancer, Depression, Hot Flashes, Psychosocial Effects of Cancer and Its Treatment | 05/14 | 12/24 | | |
ChiCTR-TRC-14004936: Ketamine's antidepressant efficacy and safety in major depression: a randomized controlled trial |
|
|
| Completed | N/A | 30 | | receive a single intravenous infusion of Ketamine+oral Escitalopram Oxalate Tablets 10mg/d four weeks ;receive a single intravenous infusion of 0.9% saline + +oral Escitalopram Oxalate Tablets 10mg/d four weeks | Beijing Chaoyang Hospital; Beijing Chaoyang Hospital, Ministry of Science and Technology; Beijing Municipal Administration of Hospitals | depression disorder | | | | |
ChiCTR-INR-17011986: Combination of Escitalopram and antipsychotic improve negative symptoms of refractory schizophrenia |
|
|
| Completed | N/A | 62 | | escitalopram ;placebo | Shandong Mental Health Center; Shandong Mental Health Center, personage | Refractory schizophrenia | | | | |
ChiCTR-IOR-16008327: A clinical evaluation research for the treatment of major depression by integrated Disease with Zheng of TCM method |
|
|
| Recruiting | N/A | 320 | | Escitalopram ;Escitalopram ;Liver resolve depression particles ;acupuncture | southern medical university; Guang'anmen Hospital, national sci-tech support plan | major depression disease | | | | |
ChiCTR-IPR-17013173: Chinese medicine Chaihu-jia-Longgu-Muli-tang in the treatment of depression: a multi-center, randomized, open lable, controlled trial |
|
|
| Recruiting | N/A | 150 | | Chaihu-jia-Longgu-Muli-tang ;Chai Mu jiaqiang Decoction ;Escitalopram ;Chaihu-jia-Longgu-Muli-tang+Escitalopram ;Lorazepam+Escitalopram | Nanjing University of Chinese Medicine; Affiliated Hospital of Integrated Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine, Science and technology project of Jiangsu Provincial Bureau of traditional Chinese Medicine | Depression | | | | |
ChiCTR-IOR-15007551: Observe the Synchronism of Brain Network-Gene Expression in Treating Depression with Electro-acupuncture |
|
|
| Not yet recruiting | N/A | 240 | | acupuncture and Escitalopram ;acupuncture ;Escitalopram | Peking University Sixth Hospital; Beijing University of Chinese Medicine, Natural Science Foundation of China | Depression | | | | |
ChiCTR1900023492: A comparative study for the effects of escitalopram and duloxetine on anhedonia in depression |
|
|
| Completed | N/A | 40 | | Escitalopram ;Duloxetine | ZhongDa Hospital, School of Medicine, Southeast University; ZhongDa Hospital, School of Medicine, Southeast University, Nanjing special fund for scientific and technological development | Major depressive disorder | | | | |
ChiCTR1800020242: Different frequencies repetitive transcranial magnetic stimulation in combination with escitalopram in female patients with somatoform disorder: single-blind, randomised, case-controlled study |
|
|
| Recruiting | N/A | 90 | | Escitalopram treatment ;10Hz rTMS plus Escitalopram treatment ;1Hz rTMS plus Escitalopram treatment | Affiliated mental health center, Tongji Medical College of Huazhong University of Science and Technology (HUST); Affiliated mental health center, Tongji Medical College of Huazhong University of Science and Technology (HUST), 2017 scientific study project of Health and Family Planning Commission of Wuhan Municipality | somatoform disorder | | | | |
ChiCTR1900021114: A Randomized, Double Blind, Controlled Trial for the Effect of Yueju Pill in The Treatment of Patient with Depression |
|
|
| Recruiting | N/A | 51 | | YUEJU PILL 12g/day+placebo ;YUEJU PILL 23g/day(week1)12g/day(week2-4)+placebo ;ESCITALOPRAM 10mg/day+placebo | The Fourth People's Hospital of Taizhou; Nanjing University of Traditional Chinese Medicine, Taizhou science and technology support(Social Development) plan for 2016/TS201612 | Depression | | | | |
ChiCTR1900026204: Canceled by the investigator. Effectiveness of rTMS in stimulating the V1 area of visual cortex versus classical target area in patients with depression: a randomized, double-blind, non-inferiority trial |
|
|
| Suspended | N/A | 70 | | rTMS therapy (L-DLPFC)+ Escitalopram oxalate tablets (10mg/d) ;rTMS therapy (left V1 area) + Escitalopram oxalate tablets (10mg/d) | Zhongda Hospital; Zhongda Hospital, Self-financing | depression | | | | |
ChiCTR2000029450: The efficacy and safety of bright light therapy combined with escitalopram oxalate in the treatment of sleep disorders associated with post-stroke depression |
|
|
| Recruiting | N/A | 110 | | escitalopram oxalat, 10 mg,qm ;escitalopram oxalat, 10 mg,qm and BLT 30min qd | The First Affiliated Hospital of Wenzhou Medical University; The First Affiliated Hospital of Wenzhou Medical University, self-financing | Post-stroke depression | | | | |
ChiCTR1800017626: A precision medicine study on the treatment of depression using Venlafaxine and Escitalopram |
|
|
| Recruiting | N/A | 4200 | | oral administration of Venlafaxine (75-225 mg/day) ;oral administration of Escitalopram (10-20 mg/day) | Zhejiang University; The First Affliated Hospital, Zhejiang University School of Medicine, National Key Research and Development Plan, Precision Medicine Research Key Special Project | Depression | | | | |
ChiCTR2000031719: Application of Objective Indicators Based on Mobile Technology in Clinical Evaluation of Depression |
|
|
| Recruiting | N/A | 60 | | Escitalopram | Beijing Anding Hospital Affiliated to Capital Medical University; The National Clinical Research Center for Mental Disorders, Beijing Anding Hospital Capital Medical University, Beijing Municipal Administration of Hospitals' Youth Programme (QML20181904) | Major Depressive Disorder | | | | |
ChiCTR2100044520: Pretest of Pharmacokinetic of Escitalopram Oxalate Tablets in healthy subjects |
|
|
| Recruiting | N/A | 8 | | Delivery order | Dongyang Hengdian hospital; Zhejiang Baidai Pharmaceutical Technology Co., Ltd., Zhejiang Baidai Pharmaceutical Technology Co., Ltd. | Pharmacokinetic study | | | | |
NCT03841474: The Recovery of Cardiovascular Patients With Depression |
|
|
| Recruiting | N/A | 150 | RoW | Psychiatric treatment with sertraline, Intervention I, Psychiatric treatment with escitalopram, Intervention II | KliniÄki BolniÄki Centar Zagreb | Coronary Artery Disease, Depression, Cardiovascular Diseases | 06/21 | 11/21 | | |
ChiCTR1800018063: Application of transcranial direct current stimulation in depression treatment |
|
|
| Not yet recruiting | N/A | 160 | | Pseudo stimulus + placebo ;Pseudo stimulus + Escitalopram ;tDCS + placebo ;tACS + placebo | Shanghai Mental Health Center; Shanghai Mental Health Center, Shanghai Shenkang Hospital Development Center Clinical Science and Technology Innovation Project | depression | | | | |
NCT03294525: Towards Neurobiology-based Diagnosis and Treatment of Affective Disorders |
|
|
| Recruiting | N/A | 400 | RoW | Escitalopram Pill, Lexapro, Duloxetine, Cymbalta, Mirtazapine Pill, Remeron, Other Antidepressants | Peking University | Affective Disorder | 12/21 | 08/22 | | |
ChiCTR1900027636: A comparative study for the efficacy of group cognitive behavior therapy and SSRIs antidepressants in the treatment of depression patients with panic attack |
|
|
| Not yet recruiting | N/A | 45 | | GCBT ;escitalopram ;GCBT+escitalopram | Peking University Sixth Hospital; Peking University Sixth Hospital, Beijing Municipal Commission of Science and Technology | Depression | | | | |
ChiCTR2100041741: Efficacy of transcranial direct current stimulation (tDCS) of treating depersonalization/derealization disorder |
|
|
| Recruiting | N/A | 80 | | F3-FP2 ;TP4-left shoulder ;Duluoxetine and escitalopram placebo ;Escitalopram and Duluoxetine placebo | Beijing Anding Hospital, Capital Medical University; Beijing Anding Hospital, Capital Medical University, Qing Miao Programme Foundation for the Talents by Beijing Hosptitals Authority | Depersonalization/realization Disorder | | | | |
ChiCTR2100049747: Efficacy Observation and the Mechanism Analysis of Ningkun Jieyu Decoction in the Treatment of Major Depressive Disorder (Liver Depression and Heat) Based on the Intestinal Flora |
|
|
| Not yet recruiting | N/A | 60 | | Granules of Ningkun Jieyu Decoction ;Escitalopram oxalate tablets (Bishike) | Xiyuan Hospital, China Academy of Chinese Medical Sciences; Xiyuan Hospital, China Academy of Chinese Medical Sciences, Qihuang Project | Major Depressive Disorder | | | | |
NCT06325605: Efficacy and Safety of Bifidobacterium Combined With High-frequency Transcranial Magnetic Stimulation in the Treatment of Adolescent Depression |
|
|
| Completed | N/A | 100 | RoW | Bifidobacterium, 0.07g/capsule, approval number: Guo Yao Zhun Zi S10950032, Shanghai Sine Pharmaceutical Co., Ltd., High-frequency rTMS, Escitalopram Oxalate, manufacturer: Sichuan Kelun Pharmaceutical Co., Ltd.; approval No.: Guo Yao Zhun Zi H20080788 | Zhen-Hong Hu | Adolescent Depression | 10/22 | 10/22 | | |
ChiCTR2000036976: The exploration of the treatment mode of electroacupuncture combined with SSRI drugs for different degrees of first-onset depression |
|
|
| Not yet recruiting | N/A | 466 | | Electroacupuncture and Escitalopram ;Sham EA and Escitalopram ;Electroacupuncture and placebo drugs ;Sham EA and Escitalopram ;Sham EA and placebo drugs | Shanghai Municipal Hospital of Traditional Chinese Medicine; Shanghai Municipal Hospital of Traditional Chinese Medicine, Government grants | Depression | | | | |
ChiCTR1900027063: Comparative study on efficacy and safety of add-on sulforaphane, rTMS as antioxidant therapies for the treatment-resistant depression. |
|
|
| Not yet recruiting | N/A | 180 | | Escitalopram 10-20mg/day, once a day, PO ;Escitalopram 10-20mg/day, once a day, PO+Sulforaphane (ZHIYINGUOSU, Shenzhen Fushan Biotech Co., Ltd.) 4~6tablets/day (be equivalent to glucosinolates 274~411 μ mol), twice a day, PO ;Escitalopram 10-20mg/day, once a day, PO+rTMS Left dorsolateral prefrontal lobe,once a day, twenty times | Shanghai Mental Health Center; Shanghai Mental Health Center, Shanghai Shenkang Hospital Development Center | Major depressive disorder | | | | |
NCT02553161: Mechanism of Antidepressant-Related Dysfunctional Arousal in High-Risk Youth |
|
|
| Completed | N/A | 214 | US | Escitalopram, Lexapro, Cognitive behavioral Psychotherapy, CBT | University of Cincinnati, National Institute of Mental Health (NIMH) | Depression, Anxiety, Bipolar Disorder | 07/22 | 12/22 | | |
NCT04977232: Adjunctive Game Intervention for Anhedonia in MDD Patients |
|
|
| Recruiting | N/A | 50 | RoW | Escitalopram, Lexapro, Game intervention | Central South University | Depression | 12/22 | 12/22 | | |
ChiCTR1900026451: Study on Brain Network of Antidepressant Effect Mechanism with Acupuncture |
|
|
| Recruiting | N/A | 74 | | Electroacupuncture ;Escitalopram Oxalate Tablets | Guangdong Province Traditional Chinese Medical Hospital; Sun Yat-Sen University, National Natural Science Foundation of China | Depression | | | | |
ChiCTR2100045350: Effects of escitalopram on social decision-making behavior and its functional brain networks in patients with depressive disorder |
|
|
| Recruiting | N/A | 60 | | Escitalopram ;None | Beijing Anding Hospital, Capital Medical University; Beijing Anding Hospital, Capital Medical University, Scientific Research Project of Beijing Educational Committee | Depressive disorder | | | | |
ChiCTR2100047797: Effects of morinda oligosaccharides on intestinal flora and 5-HT pathway in patients with mild and moderate depression |
|
|
| Not yet recruiting | N/A | 100 | | Morinda officinalis oligosaccharide ;Escitalopram oxalate | Beijing Anding Hospital, Capital Medical University; Beijing Anding Hospital, Capital Medical University, Beijing Anding Hospital, Capital Medical University and Institute of Toxicology and Drug, Academy of Military Medical Sciences | Major Depressive Disorder | | | | |
NCT05952713: Comparative Responses to 15 Different Antidepressants in Major Depressive Disorder |
|
|
| Completed | N/A | 73336 | Europe | Antidepressant, sertraline, citalopram, fluoxetine, paroxetine, escitalopram, reboxetine, venlafaxine, duloxetine, mirtazapine, vortioxetine, agomelatine, amitriptyline, imipramine | Mental Health Services in the Capital Region, Denmark, University of Copenhagen | Major Depressive Disorder | 07/23 | 07/23 | | |
NCT05588102: Electronic Training of Elderly Depression With Cognitive Impairment |
|
|
| Recruiting | N/A | 128 | RoW | Selective Serotonin Reuptake Inhibitor(SSRIs,Fluoxetine, paroxetine, fluvoxamine, sertraline, citalopram, escitalopram), Electronic cognitive training | Capital Medical University | Geriatric Depression, Cognitive Impairment | 01/24 | 01/24 | | |
ChiCTR2000029000: Randomized controlled trial for clinical optimization protocol of Xing-Pi Jie-Yu Recipe in the treatment of mild to moderate depression |
|
|
| Not yet recruiting | N/A | 130 | | Give Xingpi Jieyu Fang granules (1 dose / day, twice a day warm food) + escitalopram oxalate analog tablets 10mg / times, 1 time / d. ;Give escitalopram oxalate tablets 10mg / time, 1 time / d + Xingpi Jieyu Fang simulated granules (1 dose / day, twice a day after meal) | Dongfang Hospital of Beijing University of Chinese Medicine; Dongfang Hospital of Beijing University of Chinese Medicine, Municipal Science and Technology Funds (Research and Demonstration Application of Capital Clinical Diagnosis and Treatment Technology) | Depression | | | | |
| Recruiting | N/A | 148 | RoW | Escitalopram, Lexapro, Citalex | University of Belgrade, Clinical Centre of Serbia, Institute of Mental Health, Serbia, Military Medical Academy, Belgrade, Serbia | Depressive Disorder, Major | 09/23 | 11/23 | | |
NCT05543122: Drug Concentrations in Breast Milk and Prediction of Blood Levels of the Breastfed Infants |
|
|
| Completed | N/A | 39 | Canada | either of Atenolol, Bupropion, Brivaracetam, Escitalopram, Fluconazole, Lacosamide, Lamotrigine, Levetiracetam, Methotrexate or Ezetimibe, Typical brand names include, but not limited to: Tenoretic, Wellbutrin, Zyban, Briviact, Cipralex, Lexapro, Diflucan, Vimpat, Lamictal, Keppra, Trexall, Xatmep, Ezetrol, Nexlizet | The Hospital for Sick Children, St. Justine's Hospital, University of Waterloo | Breast Feeding | 12/23 | 03/24 | | |
ChiCTR2100054903: Study on the correlation between subjective and objective cognitive symptoms and curative effect of depression patients under the background of the construction of social psychological service system |
|
|
| Recruiting | N/A | 200 | | Escitalopram ;None | Kangci Hospital of Jiaxing; Kangci Hospital of Jiaxing, Self-raised, Kangci Hospital of Jiaxing | Depression | | | | |
ChiCTR2100043834: A controlled study of escitalopram combined with rTMS in the treatment of epileptic depression |
|
|
| Recruiting | N/A | 94 | | Escitalopram citalopram combined with repetitive transcri magnetic stimulus ;Escitalopram citalopram | Henan Mental Health Center; The Second Affiliated Hospital of Xinxiang Medical College, Henan Mental Health Center, Qianjin Road, Xinxiang City, Henan Province, China | Epilepsy suffers from depression | | | | |
LYMPHODEP, NCT06337539: Precision Psychiatry for Depression: Immune Response and Affective Symptoms as Predictors of Response to Antidepressants |
|
|
| Not yet recruiting | N/A | 50 | Europe | SSRI, Sertraline, Citalopram, Escitalopram, Fluoxetine, Paroxetine, Fluvoxamine | Germans Trias i Pujol Hospital | Depression, Inflammation, Antidepressants, Immunity | 12/26 | 07/27 | | |
| Not yet recruiting | N/A | 240 | NA | Prescription of escitalopram using pharmacogenetic testing | Centre Hospitalier Universitaire Vaudois | Pharmacogenetic Testing | 10/25 | 10/25 | | |
ChiCTR2300075062: Intraoperative single escitalopram ketamine vein or intranasal for cesarean delivery quality of maternal postpartum depression and postpartum recovery: a prospectie, randomized double-blind study |
|
|
| Not yet recruiting | N/A | 150 | | Give equal intranasal saline iv + amount of saline ;Escitalopram ketamine 0.3 mg/kg intravenous(Escitalopram ketamine concentration of 2 mg/ml) + amount of intranasal saline solution ;Escitalopram intranasal ketamine 0.6 mg/kg (escitalopram ketamine concentration of 25 mg/ml) + amount of saline iv | Fuyang city people's hospital; Fuyang city people's hospital, self-raised | Cesarean delivery quality of maternal postpartum depression and postpartum recovery | | | | |
NCT03511118: Pharmacokinetics and Safety of Commonly Used Drugs in Lactating Women and Breastfed Infants |
|
|
| Recruiting | N/A | 1600 | Canada, US | Tranexamic acid (TXA), labetalol, metformin, nifedipine, clindamycin, oxycodone, azithromycin, escitalopram, sertraline, ondansetron, Ciprofloxacin, Doxycycline, Levofloxacin, Methylphenidate, Sumatriptan, Citalopram, Cyclobenzaprine, Furosemide, Gabapentin, Hydrochlorothiazide, Hydroxyurea, Rosuvastatin, Topiramate, Trazodone, Valganciclovir, Venlafaxine, Verapamil, Remdesivir, Anakinra, Tocilizumab, Fluvoxamine, Amoxicillin, Bupropion, Duloxetine, Hydrocodone, Levetiracetam, Paroxetine, Buprenorphine | Duke University, The Emmes Company, LLC, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | Lactating Women on Select DOI, Breastfed Infants of Mothers on Select DOI | 09/24 | 09/24 | | |
| Recruiting | N/A | 84 | | ''Xingnao Kaiqiao'' acupuncture + Antidepressant acupuncture treatment ;''Xingnao Kaiqiao'' acupuncture + Escitalopram Tablets | The First Affiliated Hospital of Tianjin University of Traditional Chinese Medicine; The First Affiliated Hospital of Tianjin University of Traditional Chinese Medicine, self-funded | Post-stroke depression | | | | |
NCT05389046: Study on the Optimal Diagnosis and Treatment Strategy of Major Depressive Disorder Based on Anhedonia |
|
|
| Recruiting | N/A | 252 | RoW | Escitalopram, Escitalopram+Aripiprazole, Escitalopram+omega-3 PUFAs, Escitalopram+Aripiprazole+omega-3 PUFAs | Peking University | Outpatients / Inpatients With Depression | 12/24 | 12/25 | | |
NCT04156425: The Role of PKC Activation in the Immune-inflammatory Mechanism of Major Depressive Depression |
|
|
| Not yet recruiting | N/A | 180 | NA | Escitalopram+golimumab, Lexapro+Simponi, Escitalopram+Calcium Tablet, Lexapro+Caltrate, Escitalopram, Lexapro | Shanghai Mental Health Center | Major Depressive Disorder | 12/24 | 12/24 | | |
NCT05945342: Development and Application of Comprehensive Intervention Techniques for Adolescent Depression |
|
|
| Recruiting | N/A | 100 | RoW | Escitalopram, Interpersonal Psychotherapy for Adolescent, Escitalopram combined with psychotherapy, Escitalopram combined with rTMS, Escitalopram combined with sham rTMS | First Affiliated Hospital of Zhejiang University | Depressive Disorder, Adolescent | 12/24 | 06/25 | | |
ChiCTR2300070111: A randomized controlled clinical study on the effect of Xingshen Jieyu Decoction on resting brain default network connection in patients with moderate post-stroke depression |
|
|
| Not yet recruiting | N/A | 216 | | Placebo granules+escitalopram ;Xingshen Jieyu granules+escitalopram placebo ;Xingshen Jieyu granules+escitalopram ;Placebo granules+escitalopram placebo | Shanghai Seventh People's Hospital (the Seventh People's Hospital affiliated to Shanghai University of Traditional Chinese Medicine); Shanghai Seventh People's Hospital, the Clinical Research Program of Shanghai Science and Technology Committee under Grant No.21Y11921000 | Moderate Poststroke depression | | | | |
OPTION-VMS, NCT06049797: A Study Following Women in Menopause Treated With a Non-hormonal Therapy for Hot Flashes and Night Sweats |
|
|
| Recruiting | N/A | 1000 | US | Fezolinetant, ESN364, VEOZAH, Paroxetine, Citalopram, Escitalopram, Desvenlafaxine, Venlafaxine, Gabapentin, Clonidine, Pregabalin, Oxybutynin, Any other SSRI/SNRI not already specified, Any other non-hormonal pharmacologic therapy prescribed for the treatment of VMS not included in a category above | Astellas Pharma Global Development, Inc. | Hot Flashes | 09/25 | 09/25 | | |
ChiCTR2300071421: Fetal microbiota transplant for additional treatment of depression: a randomized, double-blind, placebo-controlled study |
|
|
| Recruiting | N/A | 60 | | Escitalopram+ FMT (0-2W); Escitalopram (3W-8W) ;Escitalopram+ placebo(0-2W);Escitalopram(3W-8W) | Beijing Anding Hospital Affiliated to Capital Medical University; Beijing Anding Hospital Affiliated to Capital Medical University, Beijing Science and Technology Plan | Major depressive disorder | | | | |
STRATIDEP, NCT05866575: Prediction of the Therapeutic Response in Depression Based on Neuro-computational Modeling Assessment of Motivation |
|
|
| Not yet recruiting | N/A | 136 | Europe | escitalopram, vortioxetine | Centre Hospitalier St Anne | Major Depressive Disorder | 11/25 | 12/26 | | |
ChiCTR2300067668: Study on Mechanism of Guipi Decoction in Treating Elderly Depression with Deficiency of Heart and Spleen Based on Cortical Plasticity |
|
|
| Not yet recruiting | N/A | 99 | | Taking Guipi Decoction ;Taking escitalopram oxalate tablets ;non-intervention | The Second People's Hospital of Lishui; The Second People's Hospital of Lishui, Zhejiang Provincial Administration of Traditional Chinese Medicine | depression | | | | |
ChiCTR2300073486: Transcutaneous Auricular Vagus Nerve Stimulation and Escitalopram for Major Depressive Disorder:A Double-blind, Factorial, Randomized, Controlled Clinical Trial |
|
|
| Not yet recruiting | N/A | 448 | | taVNS + Escitalopram pills ;taVNS + placebo pills ;tnVNS+ Escitalopram pills ;tnVNS+ placebo pills | Institute of Acupuncture and Moxibustion, China Academy of Chinese Medical Sciences; Institute of Acupuncture and Moxibustion, China Academy of Chinese Medical Sciences, The National Key R&D Program of China(2022YFC3500501) | Major Depressive Disorder(MDD) | | | | |
NCT05818735: Effect of Electroacupuncture on Treating the First-episode Depression |
|
|
| Recruiting | N/A | 204 | RoW | electroacupuncture (EA) treatment, sham acupuncture (SA) treatment, Escitalopram 10mg, real drug application, Placebo, placebo drug application | Shanghai Municipal Hospital of Traditional Chinese Medicine, Shanghai Mental Health Center, Xuhui Central Hospital, Shanghai, Shanghai Huangpu District Mental Health Center | Depression | 12/25 | 05/26 | | |
| Not yet recruiting | N/A | 216 | RoW | acupuncture, active acupuncture, escitalopram, sham-acupuncure, escitalopram placebo | Shanghai 7th People's Hospital | Depressive Disorder, Major | 09/26 | 02/27 | | |
NCT03460379: Bariatric Surgery and Pharmacokinetics of Escitalopram |
|
|
| Recruiting | N/A | 12 | Europe | Escitalopram, Citalopram, Cytalopram | Norwegian University of Science and Technology, St. Olavs Hospital, Volvat Medisinsk Senter Stokkan, Namsos Hospital, Alesund Hospital | Obesity, Morbid | 10/26 | 10/26 | | |
| Recruiting | N/A | 10000 | RoW | Escitalopram Oxalate Tablets, Lexapro, Quetiapine Fumarate Tablets, Seroquel, Lurasidone, Latuda | First Affiliated Hospital of Zhejiang University | Major Depressive Disorder, Bipolar Disorder, Mixed, Affective; Disorder, Organic | 12/26 | 12/26 | | |
| Recruiting | N/A | 400 | RoW | stepwise pharmacotherapy, escitalopram, escitalopram with aripiprazole augmentation, escitalopram with lithium augmentation, escitalopram with mirtazapine combination, antidepressant monotherapy group, escitalopram monotherapy | Chonnam National University Hospital | Major Depressive Disorder | 12/28 | 12/30 | | |
ACTRN12609000011280: Sub-chronic administration of the selective serotonin reuptake inhibitor escitalopram in healthy volunteers: drug initiation effects and the role of serotonin in experimental anxiety. |
|
|
| Recruiting | N/A | 28 | | | University of Western Australia, University of Western Australia Small Grants Scheme 2007 | anxiety, selective serotonin reuptake inhibitor (SSRI) initiation effects | | | | |